Peptide Receptor Radionuclide Therapy With 177Lu-Dotatate Associated With Metronomic Capecitabine In Patients Affected By Aggressive Gastro-Etero-Pancreatic Neuroendocrine Tumors

Name: Peptide Receptor Radionuclide Therapy With 177Lu-Dotatate Associated With Metronomic Capecitabine In Patients Affected By Aggressive Gastro-Etero-Pancreatic Neuroendocrine Tumors
License: Public Domain

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

neuroendocrine tumors, gastro entero pancreatic neuroendocrine tumors

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 481664
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.